Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive oral levetiracetam for generalized tonic-clonic seizures in patients aged 16 years and older
2014-004401-32Phase 3
- Sponsor
- UCB
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and generalized tonic-clonic seizure (GTCS) comparing Keppra adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Percentage reduction in generalized tonic-clonic seizure frequency per week over the 28-week treatment period.
02
Drugs
levetiracetam
03
Conditions
epilepsygeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2014-004401-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004401-32.